par Cardoso, Fatima
;Paesmans, Marianne
;Larsimont, Denis
;Durbecq, Virginie
;Bernard, Chantal
;Rouas, Ghizlane;Dolci, Stella;Sotiriou, Christos
;Piccart-Gebhart, Martine
;Di Leo, Angelo 
Référence Clinical breast cancer, 5, 5, page (364-369)
Publication Publié, 2004-12








Référence Clinical breast cancer, 5, 5, page (364-369)
Publication Publié, 2004-12
Article révisé par les pairs
Titre: |
|
Auteur: | Cardoso, Fatima; Paesmans, Marianne; Larsimont, Denis; Durbecq, Virginie; Bernard, Chantal; Rouas, Ghizlane; Dolci, Stella; Sotiriou, Christos; Piccart-Gebhart, Martine; Di Leo, Angelo |
Informations sur la publication: | Clinical breast cancer, 5, 5, page (364-369) |
Statut de publication: | Publié, 2004-12 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antineoplastic Agents, Hormonal -- administration & dosage |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- metabolism | |
Disease-Free Survival | |
Female | |
Follow-Up Studies | |
Humans | |
Immunohistochemistry | |
Neoadjuvant Therapy | |
Prognosis | |
Proto-Oncogene Proteins c-bcl-2 -- analysis | |
Receptors, Estrogen -- analysis | |
Survival Analysis | |
Tamoxifen -- administration & dosage | |
Treatment Outcome | |
Tumor Markers, Biological -- analysis | |
Note générale: | Journal Article |
Langue: | Anglais |
Identificateurs: | urn:issn:1526-8209 |
info:pmid/15585074 |